{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:41:20Z","timestamp":1790044880021,"version":"4.0.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T00:00:00Z","timestamp":1494028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12A3814N"],"award-info":[{"award-number":["12A3814N"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Sclerosteosis is a rare autosomal recessive bone disorder marked by hyperostosis of the skull and tubular bones. Initially, we and others reported that sclerosteosis was caused by loss-of-function mutations in SOST, encoding sclerostin. More recently, we identified disease-causing mutations in LRP4, a binding partner of sclerostin, in three sclerosteosis patients. Upon binding to sclerostin, LRP4 can inhibit the canonical WNT signaling that is known to be an important pathway in the regulation of bone formation. To further investigate the role of LRP4 in the bone formation process, we generated an Lrp4 mutated sclerosteosis mouse model by introducing the p.Arg1170Gln mutation in the mouse genome. Extensive analysis of the bone phenotype of the Lrp4R1170Q\/R1170Q knock-in (KI) mouse showed the presence of increased trabecular and cortical bone mass as a consequence of increased bone formation by the osteoblasts. In addition, three-point bending analysis also showed that the increased bone mass results in increased bone strength. In contrast to the human sclerosteosis phenotype, we could not observe syndactyly in the forelimbs or hindlimbs of the Lrp4 KI animals. Finally, we could not detect any significant changes in the bone formation and resorption markers in the serum of the mutant mice. However, the serum sclerostin levels were strongly increased and the level of sclerostin in the tibia was decreased in Lrp4R1170Q\/R1170Q mice, confirming the role of LRP4 as an anchor for sclerostin in bone. In conclusion, the Lrp4R1170Q\/R1170Q mouse is a good model for the human sclerosteosis phenotype caused by mutations in LRP4 and can be used in the future for further investigation of the mechanism whereby LRP4 regulates bone formation. \u00a9 2017 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.3160","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T09:42:34Z","timestamp":1494063754000},"page":"1739-1749","source":"Crossref","is-referenced-by-count":31,"title":["The <i>Lrp4<\/i>R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans"],"prefix":"10.1093","volume":"32","author":[{"given":"Eveline","family":"Boudin","sequence":"first","affiliation":[{"name":"Center of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Yorgan","sequence":"additional","affiliation":[{"name":"Department of Osteology and BiomechanicsUniversity Medical Center Hamburg-EppendorfHamburgGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Fijalkowski","sequence":"additional","affiliation":[{"name":"Center of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Sonntag","sequence":"additional","affiliation":[{"name":"PolyGene AGR\u00fcmlangSwitzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Steenackers","sequence":"additional","affiliation":[{"name":"Center of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretl","family":"Hendrickx","sequence":"additional","affiliation":[{"name":"Center of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Peeters","sequence":"additional","affiliation":[{"name":"Center of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"De Mar\u00e9","sequence":"additional","affiliation":[{"name":"Laboratory of PathophysiologyDepartment Biomedical SciencesUniversity of AntwerpWilrijkBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Vervaet","sequence":"additional","affiliation":[{"name":"Laboratory of PathophysiologyDepartment Biomedical SciencesUniversity of AntwerpWilrijkBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Verhulst","sequence":"additional","affiliation":[{"name":"Laboratory of PathophysiologyDepartment Biomedical SciencesUniversity of AntwerpWilrijkBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Mortier","sequence":"additional","affiliation":[{"name":"Center of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"D'Haese","sequence":"additional","affiliation":[{"name":"Laboratory of PathophysiologyDepartment Biomedical SciencesUniversity of AntwerpWilrijkBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schinke","sequence":"additional","affiliation":[{"name":"Department of Osteology and BiomechanicsUniversity Medical Center Hamburg-EppendorfHamburgGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Hul","sequence":"additional","affiliation":[{"name":"Center of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,6]]},"reference":[{"key":"2024021014200855100_jbmr3160-bib-0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2015.05.012","article-title":"LRP4 in neuromuscular junction and bone development and diseases","author":"Shen","year":"2015","journal-title":"Bone"},{"issue":"2","key":"2024021014200855100_jbmr3160-bib-0002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.semarthrit.2013.01.004","article-title":"The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases","volume":"43","author":"Boudin","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"2024021014200855100_jbmr3160-bib-0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2024021014200855100_jbmr3160-bib-0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2024021014200855100_jbmr3160-bib-0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2024021014200855100_jbmr3160-bib-0006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.33.3.267","article-title":"Sclerosteosis: neurogenetic and pathophysiologic analysis of an American kinship","volume":"33","author":"Stein","year":"1983","journal-title":"Neurology"},{"issue":"2","key":"2024021014200855100_jbmr3160-bib-0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/dbio.2002.0779","article-title":"Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators","volume":"250","author":"Balemans","year":"2002","journal-title":"Dev Biol"},{"issue":"26","key":"2024021014200855100_jbmr3160-bib-0008","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.M301716200","article-title":"Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity","volume":"278","author":"Kusu","year":"2003","journal-title":"J Biol Chem"},{"issue":"23","key":"2024021014200855100_jbmr3160-bib-0009","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"issue":"1","key":"2024021014200855100_jbmr3160-bib-0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.061002","article-title":"Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation","volume":"22","author":"van Bezooijen","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024021014200855100_jbmr3160-bib-0011","first-page":"355","article-title":"Human genetics of SOST","volume":"6","author":"Balemans","year":"2006","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"20","key":"2024021014200855100_jbmr3160-bib-0012","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"2024021014200855100_jbmr3160-bib-0013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nm0207-133","article-title":"Eating bone or adding it: the Wnt pathway decides","volume":"13","author":"Goldring","year":"2007","journal-title":"Nat Med"},{"issue":"11)","key":"2024021014200855100_jbmr3160-bib-0014","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","article-title":"Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo","volume":"4","author":"Choi","year":"2009","journal-title":"PLoS One"},{"issue":"(4","key":"2024021014200855100_jbmr3160-bib-0015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jbmr.2782","article-title":"A novel domain-specific mutation in a sclerosteosis patient suggests a role of LRP4 as an anchor for sclerostin in human bone","volume":"31","author":"Fijalkowski","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"22","key":"2024021014200855100_jbmr3160-bib-0016","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J Biol Chem"},{"issue":"12","key":"2024021014200855100_jbmr3160-bib-0017","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","article-title":"Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis","volume":"28","author":"Viaene","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2024021014200855100_jbmr3160-bib-0018","doi-asserted-by":"crossref","first-page":"e10418","DOI":"10.1371\/journal.pone.0010418","article-title":"Lrp4 regulates initiation of ureteric budding and is crucial for kidney formation\u2014a mouse model for Cenani-Lenz syndrome","volume":"5","author":"Karner","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"2024021014200855100_jbmr3160-bib-0019","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2010.03.004","article-title":"LRP4 mutations alter Wnt\/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome","volume":"86","author":"Li","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2024021014200855100_jbmr3160-bib-0020","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","article-title":"LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner","volume":"23","author":"Ohkawara","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2024021014200855100_jbmr3160-bib-0021","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaneurol.2015.0853","article-title":"Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia","volume":"72","author":"Selcen","year":"2015","journal-title":"JAMA Neurol"},{"issue":"7","key":"2024021014200855100_jbmr3160-bib-0022","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jbmr.2461","article-title":"The anti-osteoanabolic function of sclerostin is blunted in mice carrying a high bone mass mutation of Lrp5","volume":"30","author":"Yorgan","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024021014200855100_jbmr3160-bib-0023","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1083\/jcb.201207142","article-title":"Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin","volume":"200","author":"Albers","year":"2013","journal-title":"J Cell Biol"},{"issue":"6","key":"2024021014200855100_jbmr3160-bib-0024","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2024021014200855100_jbmr3160-bib-0025","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1172\/JCI200214218","article-title":"Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene","volume":"110","author":"Hoff","year":"2002","journal-title":"J Clin Invest"},{"issue":"6","key":"2024021014200855100_jbmr3160-bib-0026","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nm.1963","article-title":"Impaired gastric acidification negatively affects calcium homeostasis and bone mass","volume":"15","author":"Schinke","year":"2009","journal-title":"Nat Med"},{"issue":"16","key":"2024021014200855100_jbmr3160-bib-0027","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2024021014200855100_jbmr3160-bib-0028","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00439-009-0773-z","article-title":"Genetics of osteoporosis: accelerating pace in gene identification and validation","volume":"127","author":"Li","year":"2010","journal-title":"Hum Genet"},{"issue":"8","key":"2024021014200855100_jbmr3160-bib-0029","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7326\/0003-4819-151-8-200910200-00006","article-title":"Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture","volume":"151","author":"Richards","year":"2009","journal-title":"Ann Intern Med"},{"issue":"11","key":"2024021014200855100_jbmr3160-bib-0030","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ng.446","article-title":"Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies","volume":"41","author":"Rivadeneira","year":"2009","journal-title":"Nat Genet"},{"issue":"24","key":"2024021014200855100_jbmr3160-bib-0031","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development"},{"issue":"1","key":"2024021014200855100_jbmr3160-bib-0032","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ydbio.2013.08.015","article-title":"Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner","volume":"383","author":"Collette","year":"2013","journal-title":"Dev Biol"},{"issue":"6","key":"2024021014200855100_jbmr3160-bib-0033","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"48","key":"2024021014200855100_jbmr3160-bib-0034","doi-asserted-by":"crossref","first-page":"E5187","DOI":"10.1073\/pnas.1413828111","article-title":"Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2024021014200855100_jbmr3160-bib-0035","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1073\/pnas.1419714112","article-title":"Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption","volume":"112","author":"Xiong","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2024021014200855100_jbmr3160-bib-0036","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00223-016-0154-2","article-title":"HBM mice have altered bone matrix composition and improved material toughness","volume":"99","author":"Ross","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"2024021014200855100_jbmr3160-bib-0037","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.2003.18.6.960","article-title":"High bone mass in mice expressing a mutant LRP5 gene","volume":"18","author":"Babij","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024021014200855100_jbmr3160-bib-0038","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat Med"},{"issue":"12","key":"2024021014200855100_jbmr3160-bib-0039","doi-asserted-by":"crossref","first-page":"e4092","DOI":"10.1371\/journal.pone.0004092","article-title":"Lrp4 modulates extracellular integration of cell signaling pathways in development","volume":"3","author":"Ohazama","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"2024021014200855100_jbmr3160-bib-0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"Cejka","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024021014200855100_jbmr3160-bib-0041","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1210\/jc.2013-3278","article-title":"Serum Dickkopf 1 levels in sclerostin deficiency","volume":"99","author":"van Lierop","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014200855100_jbmr3160-bib-0042","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat Commun"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3160","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/32\/8\/1739\/56651560\/jbmr3160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/32\/8\/1739\/56651560\/jbmr3160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:59:02Z","timestamp":1710341942000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/32\/8\/1739-1749\/7605470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,6]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,6]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3160","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8,1]]},"published":{"date-parts":[[2017,5,6]]}}}